73%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
73%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
73%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
73%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Neogen Corp
Closed
SectorHealthcare
10.27 0.39
Overview
Share price change
24h
Min
10.18
Max
10.85
Income | -52M -16M |
|---|---|
Sales | 16M 225M |
Profit margin | -7.087 |
Employees | 2,974 |
EBITDA | -66M 23M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +4.4% upside |
Next Earnings | 8 Apr 2026 |
|---|
Market Cap | 600M 2.2B |
|---|---|
Previous open | 9.88 |
Previous close | 10.27 |
Technical Score
By Trading Central
Confidence
Strong Bullish Evidence
Neogen Corp Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Neogen Corp Forecast
Price Target
By TipRanks
4.4% upside
12 Months Forecast
Average 10.67 USD 4.4%
High 12 USD
Low 10 USD
Based on 4 Wall Street analysts offering 12 month price targets forNeogen Corp - Dist in the last 3 months.
Sentiment
By Acuity
296 / 352 Healthcare
News Sentiment
Bearish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Neogen Corp
Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared food products and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. The company was incorporated in 1981 and is headquartered in Lansing, Michigan.
Live chat